In the PATHFINDER 2 trial, the study investigators will test the intraoperative EEG-guided multimodal general anesthesia (MMGA) management strategy in combination with a postoperative protocolized analgesic approach to: 1. reduce the incidence of perioperative neurocognitive dysfunction in cardiac surgical patients 2. ensure hemodynamic stability and decrease use of vasopressors in the operating rooms 3. reduce pain and opioid consumption postoperatively
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Increase in Plasma IL-6 Levels
Timeframe: Baseline, postoperative day 1, and postoperative day 2
Increase in Plasma Neurofilament Light Levels
Timeframe: Baseline, postoperative day 1, and postoperative day 2